Flow Injection Analysis Tandem Mass Spectrometry (FIA-MS/MS) in the Clinical Laboratory: Lessons from Newborn Screening Ontario (NSO)
26 Mar 2018
Maintaining Accuracy and Consistency of Results in FIA-MS/MS
Attend this hour-long educational webinar to learn how to address some current challenges in FIA-MS/MS and maximize the benefits of this technique using Waters' technologies. You will hear recommendations from expert speakers with extensive experience of analyzing amino acids and acylcarnitines from dried blood spots in a clinical environment. Techniques such as multiple reaction monitoring (MRM), neutral loss scanning, and precursor ion identification from fragment ions will be discussed, and examples of common troubleshooting approaches will be provided. By registering you will also have the opportunity to put your question to the panel of speakers during the Q&A.
Key learning objectives
After attending this session, the participants will be able to:
- Describe the post-analytical activities that should be followed daily, weekly and monthly
- Discuss the benefits of monitoring and changing the response factors to maintain analytical accuracy
- Review the impact of monitoring mass accuracy
Who should attend?
Laboratory technologists, laboratory scientists, chemical pathologists, clinical and biomedical scientists and researchers who use FIA-MS/MS in routine or research applications.
Certificate of attendance
All webinar participants can request a certificate of attendance, and a learning outcomes summary document for continuing education purposes.
Newborn Screening Ontario (NSO), located at the Children’s Hospital of Eastern Ontario (CHEO), is the provincial program that coordinates newborn screening of over 140,000 infants each year in Ontario, Canada. Their multi-disciplinary team provides a comprehensive program of analysis, follow-up, education, research and development.Waters